Article

New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA Approved Drugs and Biologics

2023-07-28

Abstract excerpt

<title>Abstract</title> <p>Background A lack of diversity and representation in clinical trials is an established issue in drug development, and the COVID-19 pandemic increased awareness of the problem among the general public. This awareness has led to increased pressure on drug development sponsors, as well as additional attention and regulation from federal bodies, to improve the diversity of clinical trials....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f0baf418-a791-587b-9493-013c7adc07b2
DOI: 10.21203/rs.3.rs-3117430/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA Approved Drugs and BiologicsDOI 10.21203/rs.3.rs-3117430/v1Read

The Dearth of Representation in FDA Approved Drug TrialsSemantic proximity Read

Current State and Demographic Trends of Medically Underserved Populations in Rare Disease Research in the United StatesSemantic proximity Read

Sex Representation in U.S. Clinical Trials: A Statistical Benchmarking StudySemantic proximity Read

The Current Landscape of Clinical TrialsSemantic proximity Read

Global Inequities in Precision Oncology Drug Development: A Cross-Sectional Analysis of FDA Approvals Between 2017-2024Semantic proximity Read

Racial and Ethnic Diversity in Clinical Studies Reported to ClinicalTrials.gov, 2009-2024Semantic proximity Read

Eligibility for Human Leukocyte Antigen-Based Therapeutics by Race and Ethnicity.Semantic proximity Read

The Sparse Matrix of Drug Discovery: Sex, Race, and a Genomic Equity Index Across 40.8 Million Patients in 77,770 Clinical TrialsSemantic proximity Read

Demographic Representation of a Decentralized Long COVID Trial: A Comparison with the 2023 National Health Interview SurveySemantic proximity Read

A Systematic Review of Representation in Clinical Trials for Transthyretin Associated Cardiac Amyloidosis: Where Demographics Diverge from DiseaseSemantic proximity Read

A Framework for Inclusive and Accessible Clinical Research in Rare DiseasesSemantic proximity Read

Adequate Underrepresented Minority Representation in Cancer Trials: Evidence from an NCI-Designated Center in a Minority CountySemantic proximity Read